<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10527">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00654511</url>
  </required_header>
  <id_info>
    <org_study_id>3502</org_study_id>
    <secondary_id>Agreement #10698</secondary_id>
    <nct_id>NCT00654511</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy</brief_title>
  <acronym>DexT&amp;A</acronym>
  <official_title>Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospira, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Research Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is:

        1. To compare dexmedetomidine with fentanyl in terms of intra-operative hemodynamics and
           post-operative analgesia.

        2. To determine an analgesic dose response relationship for dexmedetomidine.

        3. Compare recovery characteristics of dexmedetomidine to fentanyl.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Time to First Morphine Dose</measure>
    <time_frame>up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total minutes from study medication administration to time of first morphine dose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphine Rescue</measure>
    <time_frame>up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total morphine administered in the Post Anesthesia Care Unit (PACU)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Tonsillitis</condition>
  <arm_group>
    <arm_group_label>Fentanyl 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl 1 micrograms (mcg)/kilogram (kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl 2 micrograms (mcg)/kilogram (kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dex 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 2 micrograms (mcg)/kilogram (kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dex 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 4 micrograms (mcg)/kilogram (kg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 1mcg/kg, Intravenous (IV)</description>
    <arm_group_label>Fentanyl 1</arm_group_label>
    <other_name>Actiq</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 2mcg/kg, Intravenous (IV)</description>
    <arm_group_label>Fentanyl 2</arm_group_label>
    <other_name>Actiq</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine, 2mcg/kg, Intravenous (IV)</description>
    <arm_group_label>Dex 3</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine, 4mcg/kg Intravenous (IV)</description>
    <arm_group_label>Dex 4</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All of the following criteria must be met for the potential subject to be eligible
             for participation:

               1. The subject is 2 to 12 years of age

               2. The subject's American Society of Anesthesiologists physical status is ASA I or
                  II (see appendix 1).

               3. The subject is scheduled for elective tonsillectomy with or without
                  adenoidectomy surgery (procedures with myringotomy tube placement are allowed).

               4. The subject will be hospitalized overnight after surgery

               5. The subject's parent/legally authorized guardian has given written informed
                  consent to participate; and where applicable, the subject has given appropriate
                  assent to participate.

                  Exclusion Criteria:

          -  The potential subject is NOT eligible for participation if any of the following
             exclusion criteria apply:

               1. The subject has a history or a family (parent or sibling) history of malignant
                  hyperthermia

               2. The subject has known significant renal or hepatic disorders determined by
                  medical history, physical examination or laboratory tests.

               3. The subject has a known or suspected allergy to opioid analgesics

               4. The subject is a pregnant or lactating female (if post-menarcheal, a negative
                  pregnancy test must be confirmed prior to the planned surgery time (in AMSAC)
                  consistent with current standard of care.

               5. The subject has history of. cardiovascular issues which would preclude the use
                  of dexmedetomidine, (e.g. Down's Syndrome, dysrhthymias, conditions where
                  hypotension is to be avoided).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia C Finkel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <lastchanged_date>March 28, 2011</lastchanged_date>
  <firstreceived_date>April 3, 2008</firstreceived_date>
  <firstreceived_results_date>February 23, 2011</firstreceived_results_date>
  <responsible_party>
    <name_title>Julia C. Finkel, MD</name_title>
    <organization>Children's National Medical Center</organization>
  </responsible_party>
  <keyword>Dexmedetomidine,</keyword>
  <keyword>fentanyl,</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>and adenoidectomy,</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fentanyl 1 Microgram/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 1 microgram/kilogram IV given immediately after endotracheal intubation.</description>
        </group>
        <group group_id="P2">
          <title>Fentanyl 2 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 2 micrograms/kilogram IV given immediately after endotracheal intubation</description>
        </group>
        <group group_id="P3">
          <title>Dexmedetomidine 2 Microgram/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 2mcg/kg given immediately after endotracheal intubation</description>
        </group>
        <group group_id="P4">
          <title>Dexmedetomidine 4 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 4mcg/kg given immediately after endotracheal intubation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fentanyl 1 Microgram/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 1 microgram/kilogram IV given immediately after endotracheal intubation.</description>
        </group>
        <group group_id="B2">
          <title>Fentanyl 2 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 2 micrograms/kilogram IV given immediately after endotracheal intubation</description>
        </group>
        <group group_id="B3">
          <title>Dexmedetomidine 2 Microgram/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 2mcg/kg given immediately after endotracheal intubation</description>
        </group>
        <group group_id="B4">
          <title>Dexmedetomidine 4 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 4mcg/kg given immediately after endotracheal intubation</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="25"/>
                <measurement group_id="B3" value="25"/>
                <measurement group_id="B4" value="25"/>
                <measurement group_id="B5" value="101"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="25"/>
                <measurement group_id="B3" value="25"/>
                <measurement group_id="B4" value="25"/>
                <measurement group_id="B5" value="101"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
                <measurement group_id="B5" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
                <measurement group_id="B5" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="4.17" spread="2.33"/>
                <measurement group_id="B2" value="4.83" spread="2.45"/>
                <measurement group_id="B3" value="5.17" spread="2.33"/>
                <measurement group_id="B4" value="4.92" spread="2.27"/>
                <measurement group_id="B5" value="4.77" spread="2.34"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="12"/>
                <measurement group_id="B4" value="11"/>
                <measurement group_id="B5" value="43"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="14"/>
                <measurement group_id="B3" value="13"/>
                <measurement group_id="B4" value="14"/>
                <measurement group_id="B5" value="58"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="26"/>
                <measurement group_id="B2" value="25"/>
                <measurement group_id="B3" value="25"/>
                <measurement group_id="B4" value="25"/>
                <measurement group_id="B5" value="101"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to First Morphine Dose</title>
        <description>Total minutes from study medication administration to time of first morphine dose.</description>
        <time_frame>up to 24 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl 1 Microgram/Kilogram IV</title>
          </group>
          <group group_id="O2">
            <title>Fentanyl 2 Micrograms/Kilogram IV</title>
          </group>
          <group group_id="O3">
            <title>Dexmedetomidine 2 Microgram/Kilogram IV</title>
          </group>
          <group group_id="O4">
            <title>Dexmedetomidine 4 Micrograms/Kilogram IV</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="25"/>
                  <measurement group_id="O3" value="25"/>
                  <measurement group_id="O4" value="25"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Time to First Morphine Dose</title>
            <description>Total minutes from study medication administration to time of first morphine dose.</description>
            <units>minutes</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="19" spread="24.8"/>
                  <measurement group_id="O2" value="43.7" spread="61.4"/>
                  <measurement group_id="O3" value="61.1" spread="89.5"/>
                  <measurement group_id="O4" value="137.6" spread="123.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Morphine Rescue</title>
        <description>Total morphine administered in the Post Anesthesia Care Unit (PACU)</description>
        <time_frame>up to 24 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl 1 Microgram/Kilogram Intravenous (IV)</title>
            <description>Fentanyl 1 microgram/kilogram IV given immediately after endotracheal intubation.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl 2 Micrograms/Kilogram Intravenous (IV)</title>
            <description>Fentanyl 2 micrograms/kilogram IV given immediately after endotracheal intubation</description>
          </group>
          <group group_id="O3">
            <title>Dexmedetomidine 2 Microgram/Kilogram Intravenous (IV)</title>
            <description>Dexmedetomidine 2mcg/kg given immediately after endotracheal intubation</description>
          </group>
          <group group_id="O4">
            <title>Dexmedetomidine 4 Micrograms/Kilogram Intravenous (IV)</title>
            <description>Dexmedetomidine 4mcg/kg given immediately after endotracheal intubation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="26"/>
                  <measurement group_id="O2" value="25"/>
                  <measurement group_id="O3" value="25"/>
                  <measurement group_id="O4" value="25"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Morphine Rescue</title>
            <description>Total morphine administered in the Post Anesthesia Care Unit (PACU)</description>
            <units>micrograms/kilogram</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="84" spread="37"/>
                  <measurement group_id="O2" value="95" spread="44"/>
                  <measurement group_id="O3" value="85" spread="37"/>
                  <measurement group_id="O4" value="59" spread="44"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fentanyl 1 Microgram/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 1 microgram/kilogram IV given immediately after endotracheal intubation.</description>
        </group>
        <group group_id="E2">
          <title>Fentanyl 2 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Fentanyl 2 micrograms/kilogram IV given immediately after endotracheal intubation</description>
        </group>
        <group group_id="E3">
          <title>Dexmedetomidine 2 Microgram/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 2mcg/kg given immediately after endotracheal intubation</description>
        </group>
        <group group_id="E4">
          <title>Dexmedetomidine 4 Micrograms/Kilogram Intravenous (IV)</title>
          <description>Dexmedetomidine 4mcg/kg given immediately after endotracheal intubation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy</name_or_title>
      <organization>Children's National Medical Center</organization>
      <phone>202-476-4867 ext 4867</phone>
      <email>jfinkel@cnmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
